ARG1 and Alzheimer disease: In addition, Arginase 1 was shown to be upregulated in 9-months 3xTg-AD hippocampi and revealed to reduce Aβ plaque formation in conditions of IL-1β-dependent inflammation [87], as happened in our model with upregulated hippocampal IL-1β at this stage.